Back to search
Ischemic Stroke, Hyperacute
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ischemic Stroke, Hyperacute trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ischemic Stroke, Hyperacute trials you may qualify forThe primary objective of this study is to further define the mechanisms of action of Mexidol® (solution for intravenous and intramuscular injection, 50 mg/ml) a…
The goal of this clinical trial is to learn if a combination of antiplatelet drugs works better than intravenous tissue plasminogen activator to treat small isc…
To explore the safe and efficacious dose of rhTNK-tPA injection administered within 3 hours after onset of hyperacute ischemic stroke; to provide dose evidence…
Placing the head of bed (HOB) at 0-degrees has been shown in small studies to improve blood flow to the brain in patients with ischemic stroke caused by large a…
Stroke has an enormous impact on both individual and society. Novel treatments are required to relieve this burden and remote ischaemic conditioning (RIC) is on…